Basic information
Biomarker: hGH
Histology type: endometrial carcinoma
Cohort characteristics
Country: China
Region: Hefei
Followed up time :
Subgroup 1 name : mRNA
Subgroup 1 number: 34
Subgroup 2 name: Protein
Subgroup 2 number: 41
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
140 | EC | 70 | hyperplasia | 32 | normal controls | 38 |
Sample information
Conclusion: Tumor expression of hPRL expression, individually and combined, are associated with worse relapse-free survival and overall survival in patients with mammary or endometrial carcinoma.
Sample type : tissue
Sample method: situ hybridization and immunohistochemistry
Expression pattern : positive expression
Expression elevation: The sections were scored on the basis of the staining intensity and the percentage of cells with staining relative to the background: negative (-), having fewer than 10% of the epithelial cells stained positive; positive (+), having more than 10% of the cells stained positive.
Disease information
Statictics: cutoff<60;cutoff>60
Cohort age: 57;13
Subgroup 1 age: 31;8
Subgroup 2 age: 32;8
Related information
Funtion Uniprot: Plays an important role in growth control. Its major role in stimulating body growth is to stimulate the liver and other tissues to secrete IGF-1. It stimulates both the differentiation and proliferation of myoblasts. It also stimulates amino acid uptake and protein synthesis in muscle and other tissues.
UniProt ID: P01241
UniProt Link: https://www.uniprot.org/uniprotkb/P01241/entry#function
Molecular function from UniProt:
Subcellular UniProt: #Secreted
Alternative name from UniProt:
Miscellaneous: Circulating GH shows a great heterogeneity due to alternative splicing, differential post-translational modifications of monomeric forms, oligomerization, optional binding to 2 different GH-binding proteins, and potentially proteolytic processing.
Recommended name: Somatotropin
Gene name from HGNC: GH1 (GH, GH-N, GHN, hGH-N)
HPA class: Cancer-related genes Candidate cardiovascular disease genes Disease related genes Human disease related genes
AlphaFold DB: P01241
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P01241
HPA link: https://www.proteinatlas.org/ENSG00000259384-GH1
Tissue specificity RNA from HPA: Tissue enriched (pituitary gland)
Tissue expression from HPA: Cytoplasmic expression in cells in anterior pituitary gland and placenta.
Single cell type specificity Cell type enhanced (Adipocytes)
Immune cell specificity: Not detected in immune cells
Cancer prognostic summary HPA Gene product is not prognostic
Pathology link: https://www.proteinatlas.org/ENSG00000259384-GH1/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000259384-GH1/pathology/endometrial+cancer
Phenotype ID: 262400;612781;
Disease: Growth hormone deficiency, isolated, 1A (IGHD1A);Growth hormone deficiency, isolated, 1B (IGHD1B);Kowarski syndrome (KWKS);
Note1: The disease is caused by variants affecting the gene represented in this entry;The disease is caused by variants affecting the gene represented in this entry;The disease is caused by variants affecting the gene represented in this entry;
OMIM: 139250
OMIM link1: https://www.omim.org/entry/262400;https://www.omim.org/entry/612781;https://www.omim.org/entry/262650;
OMIM link2: https://www.omim.org/entry/139250
HGNC ID: HGNC:4261
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4261